G. Vercauteren

1.7k total citations
25 papers, 929 citations indexed

About

G. Vercauteren is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, G. Vercauteren has authored 25 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 16 papers in Infectious Diseases and 9 papers in Epidemiology. Recurrent topics in G. Vercauteren's work include HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (5 papers). G. Vercauteren is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (5 papers). G. Vercauteren collaborates with scholars based in Belgium, Switzerland and United States. G. Vercauteren's co-authors include Guido van der Groen, Robert Colebunders, Peter Piot, Luc Kestens, Chris Vereecken, P. Gigase, M Vandenbruaene, Guido Vanham, Anita Sands and Ana del Pozo‐Rodríguez and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

G. Vercauteren

24 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Vercauteren Belgium 16 573 495 385 147 139 25 929
D. A. Cooper Australia 8 773 1.3× 682 1.4× 666 1.7× 191 1.3× 105 0.8× 15 1.4k
S Cassol Canada 16 913 1.6× 872 1.8× 428 1.1× 115 0.8× 72 0.5× 27 1.4k
Sandra Emery United States 16 512 0.9× 489 1.0× 273 0.7× 119 0.8× 69 0.5× 21 893
Matthew Lukwiya Italy 11 724 1.3× 272 0.5× 192 0.5× 143 1.0× 111 0.8× 13 1.0k
Roel A. Coutinho Netherlands 19 627 1.1× 616 1.2× 540 1.4× 207 1.4× 147 1.1× 27 1.1k
Phyllis Kanki United States 20 772 1.3× 651 1.3× 331 0.9× 146 1.0× 73 0.5× 61 1.2k
Ronan Doorly United States 10 618 1.1× 214 0.4× 462 1.2× 61 0.4× 68 0.5× 10 882
Vicharn Vithayasai Thailand 11 627 1.1× 430 0.9× 335 0.9× 136 0.9× 59 0.4× 31 948
Richard Pilon Canada 17 662 1.2× 647 1.3× 400 1.0× 104 0.7× 36 0.3× 39 1.0k
Anders Nauclér Sweden 19 573 1.0× 549 1.1× 311 0.8× 221 1.5× 33 0.2× 34 986

Countries citing papers authored by G. Vercauteren

Since Specialization
Citations

This map shows the geographic impact of G. Vercauteren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Vercauteren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Vercauteren more than expected).

Fields of papers citing papers by G. Vercauteren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Vercauteren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Vercauteren. The network helps show where G. Vercauteren may publish in the future.

Co-authorship network of co-authors of G. Vercauteren

This figure shows the co-authorship network connecting the top 25 collaborators of G. Vercauteren. A scholar is included among the top collaborators of G. Vercauteren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Vercauteren. G. Vercauteren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wade, Djibril, Géraldine Daneau, Said Aboud, et al.. (2014). WHO Multicenter Evaluation of FACSCount CD4 and Pima CD4 T-Cell Count Systems. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(5). e98–e107. 30 indexed citations
2.
Vercauteren, G., et al.. (2012). Halicephalobus gingivalis Infection in a Horse. Journal of Comparative Pathology. 146(1). 71–71.
3.
Mofenson, Lynne, Gayle Sherman, Martina Penazzato, et al.. (2010). WHO recommendations on the diagnosis of HIV infection in infants and children. Zurich Open Repository and Archive (University of Zurich). 94 indexed citations
4.
Vinelli, Elizabeth, Louis V. Kirchhoff, Ana del Pozo‐Rodríguez, et al.. (2009). WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 49(6). 1076–1082. 99 indexed citations
5.
Schinaia, Nicola, et al.. (2004). The use of blood donor data for HIV surveillance purposes. AIDS. 18(13). 1849–1851. 7 indexed citations
6.
Beelaert, Greet, et al.. (2002). Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV. Journal of Virological Methods. 105(2). 197–206. 22 indexed citations
7.
Fonck, K, et al.. (1997). Tuberculosis, HIV, hepatitis B and risk behaviour in a Belgian prison. 55. 87–97. 9 indexed citations
8.
Schopper, Doris & G. Vercauteren. (1996). Testing for HIV at home: what are the issues?. AIDS. 10(13). 1455–1465. 16 indexed citations
9.
Vercauteren, G., Greet Beelaert, & Guido van der Groen. (1995). Evaluation of an agglutination HIV-1 + 2 antibody assay. Journal of Virological Methods. 51(1). 1–8. 6 indexed citations
10.
Kestens, Luc, Guido Vanham, Chris Vereecken, et al.. (1994). Selective increase of activation antigens HLA-DR and CD38 on CD45RO+ T lymphocytes during HIV-1 infection. Clinical & Experimental Immunology. 95(3). 436–441. 148 indexed citations
11.
Goubau, Patrick, H. Carton, G. Vercauteren, et al.. (1992). Human T‐cell lymphotropic virus type 1 infection and tropical spastic paraparesis in belgian expatriates. Journal of Medical Virology. 36(1). 13–15. 10 indexed citations
12.
Nkengasong, John N., et al.. (1992). Alternative confirmatory strategy for anti-HIV antibody detection. Journal of Virological Methods. 36(2). 159–169. 13 indexed citations
13.
Fransen, Katrien, D E Pollet, Martine Peeters, et al.. (1991). Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2. European Journal of Clinical Microbiology & Infectious Diseases. 10(11). 939–946. 15 indexed citations
14.
Behets, Frieda, R. W. Ryder, Peter Piot, et al.. (1991). Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa. Journal of Clinical Microbiology. 29(10). 2280–2284. 18 indexed citations
15.
Colebunders, Robert, R. W. Ryder, Henry Francis, et al.. (1991). Seroconversion Rate, Mortality, and Clinical Manifestations Associated with the Receipt of a Human Immunodeficiency Virus-Infected Blood Transfusion in Kinshasa, Zaire. The Journal of Infectious Diseases. 164(3). 450–456. 45 indexed citations
16.
Vercauteren, G., et al.. (1991). Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.. PubMed. 69(6). 753–60. 46 indexed citations
17.
Braddick, M R, J Kreiss, Joanne E. Embree, et al.. (1990). Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS. 4(10). 1001–1006. 94 indexed citations
18.
Laga, Marie, Henri Taelman, Patrick Van der Stuyft, et al.. (1989). Advanced immunodeficiency as a risk factor for heterosexual transmission of HIV. AIDS. 3(6). 361–366. 27 indexed citations
19.
Groen, Guido van der, G. Vercauteren, & Peter Piot. (1987). Immunofluorescence tests for HIV antibody and their value as confirmatory tests. Journal of Virological Methods. 17(1-2). 35–43. 12 indexed citations
20.
Vercauteren, G., Guido van der Groen, & Peter Piot. (1987). Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera. European Journal of Clinical Microbiology & Infectious Diseases. 6(2). 132–135. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. A. Cooper Breakdown of academic impact, for papers by S Cassol Breakdown of academic impact, for papers by Sandra Emery Breakdown of academic impact, for papers by Matthew Lukwiya Breakdown of academic impact, for papers by Roel A. Coutinho Breakdown of academic impact, for papers by Phyllis Kanki Breakdown of academic impact, for papers by Ronan Doorly Breakdown of academic impact, for papers by Vicharn Vithayasai Breakdown of academic impact, for papers by Richard Pilon Breakdown of academic impact, for papers by Anders Nauclér
Rankless by CCL
2026